Thank you for the question, Ms. Adams.
I identified in my opening comments a number of the aspects of the bill of which we are extremely supportive. I'll just mention some of those.
First of all is the inclusion of increasing penalties on those manufacturers who essentially wilfully put unsafe products on the market. Obviously the recall powers for Health Canada have long been absent, as you mentioned. The requirement for companies to revise labels to clearly reflect health risks is important. We welcome the reporting of adverse reactions, although again perhaps with some greater clarity in terms of how that would actually be applied. There is also the notion or the power to compel companies to do further testing of products, especially when at-risk populations are identified.
We think all of these are extremely welcome aspects of the bill.